insights_auto
Why is NEO down 13.33%?
Dive Deeperchevron_right
NEO:NASDAQ
NeoGenomics, Inc.
$16.58
arrow_downward
-13.33%(-2.55) 1D
Oct 6, 2:53:07 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
$20.00
High
$20.15
Low
$16.56
Mkt. cap
2.06B
Avg. vol.
2.06M
Volume
3.49M
52-wk high
$20.15
52-wk low
$7.06
EPS
-$0.40
Beta
1.79
Shares outstanding
128.48M
No. of employees
2K
Open
$20.00
High
$20.15
Low
$16.56
Mkt. cap
2.06B
Avg. vol.
2.06M
Volume
3.49M
52-wk high
$20.15
52-wk low
$7.06
EPS
-$0.40
Beta
1.79
Shares outstanding
128.48M
No. of employees
2K
News stories
From web sources and news partners
marketscreener.com
·
18 minutes ago
NeoGenomics on 'More Solid Footing' With Strong Revenue Growth, Needham Says
Benzinga
·
1 hour ago
What's Going On With NeoGenomics Stock Tuesday?
Seeking Alpha
·
1 hour ago
NeoGenomics stock down after leadership transition (NEO:NASDAQ)
TIKR.com
·
1 hour ago
NeoGenomics Sinks 12% on CEO Succession Plan Despite Revenue Beat
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2.5K
Founded2002
HeadquartersFort Myers, Florida, United States
SectorHealth care provider
Websiteneogenomics.com